ArticlePharmaceutics2018

Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies.

Nivesh K Mittal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.